Thermo Fisher Scientific Inc (TMO)
Return on total capital
| Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | ||
|---|---|---|---|---|---|---|
| Earnings before interest and tax (EBIT) | US$ in thousands | 8,109,000 | 8,692,000 | 6,859,000 | 8,561,000 | 9,377,000 |
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 53,415,000 | 49,584,000 | 46,735,000 | 43,978,000 | 40,793,000 |
| Return on total capital | 15.18% | 17.53% | 14.68% | 19.47% | 22.99% |
December 31, 2025 calculation
Return on total capital = EBIT ÷ (Long-term debt + Total stockholders’ equity)
= $8,109,000K ÷ ($—K + $53,415,000K)
= 15.18%
Peer comparison
Dec 31, 2025
Company name
Symbol
Return on total capital
Thermo Fisher Scientific Inc
TMO
15.18%
Agilent Technologies Inc
A
22.95%
Danaher Corporation
DHR
8.56%